Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
benign prostatic hyperplasia
MedTech
Boston Scientific bumps financial forecasts amid device gains
The company logged a 22.8% increase in sales for 2025’s second quarter, pushing its total revenue haul to above $5 billion.
Conor Hale
Jul 23, 2025 10:32am
Procept BioRobotics gets FDA nod for prostate surgery system
Aug 23, 2024 1:00pm
Nymox CEO calls ex-staffers' rebellion 'transparent mischief'
Mar 27, 2024 11:12am
Laborie picks up Urotronic and its BPH balloon for $600M
Sep 6, 2023 10:45am
FDA greenlights Urotronic's drug-coated balloon for BPH
Jul 17, 2023 10:28am
Nymox faces rebellion led by former execs over stalled deal
Jul 10, 2023 9:05am
